Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse

被引:0
|
作者
Paul Shapshak
Charurut Somboonwit
Lydia N. Drumright
Simon D.W. Frost
Deborah Commins
Timothy L. Tellinghuisen
William K. Scott
Robert Duncan
Clyde McCoy
J. Bryan Page
Brian Giunta
Francisco Fernandez
Elyse Singer
Andrew Levine
Alireza Minagar
Oluwadayo Oluwadara
Taiwo Kotila
Francesco Chiappelli
John T. Sinnott
机构
[1] University of South Florida Health,Division of Infectious Disease and International Medicine, Department of Internal Medicine
[2] College of Medicine,Department of Psychiatry and Behavioral Medicine
[3] University of South Florida,Hillsborough Health Department
[4] College of Medicine,Division of International Health, Department of Medicine
[5] Clinical Research Unit,Department of Veterinary Medicine
[6] University of California,Department of Pathology
[7] University of Cambridge,Miami Institute for Human Genomics
[8] University of Southern California Keck School of Medicine,Department of Epidemiology, Comprehensive Drug Research Center
[9] Scripps Research Institute,Department of Anthropology, University of Miami, Coral Gables, and Department of Psychiatry and Behavioral Sciences, Comprehensive Drug Research Center
[10] University of Miami Miller School of Medicine,Department of Neurology and National Neurological AIDS Bank
[11] University of Miami Miller School of Medicine,Department of Neurology
[12] University of Miami Miller School of Medicine,Division of Oral Biology and Medicine
[13] UCLA School of Medicine,Department of Anatomy, College of Medicine
[14] Louisiana State University Health Sciences Center,Department of Hematology
[15] UCLA School of Dentistry,undefined
[16] University of Ibadan,undefined
[17] College of Medicine and University College Hospital,undefined
[18] University of Ibadan,undefined
来源
关键词
Treg Cell; Injection Drug Abuse;
D O I
暂无
中图分类号
学科分类号
摘要
The spread of hepatitis C virus (HCV) infection involves a complex interplay of social risks, and molecular factors of both virus and host. Injection drug abuse is the most powerful risk factor for HCV infection, followed by sexual transmission and additional non-injection drug abuse factors such as co-infection with other viruses and barriers to treatment. It is clearly important to understand the wider context in which the factors related to HCV infection occur. This understanding is required for a comprehensive approach leading to the successful prevention, diagnosis, and treatment of HCV. An additional consideration is that current treatments and advanced molecular methods are generally unavailable to socially disadvantaged patients. Thus, the recognition of behavioral/social, viral, and host factors as components of an integrated approach to HCV is important to help this vulnerable group. Equally important, this approach is key to the development of personalized patient treatment — a significant goal in global healthcare.
引用
收藏
页码:153 / 179
页数:26
相关论文
共 50 条
  • [31] Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users
    Maryam Sheikh
    Farah Bokharaei-Salim
    Seyed Hamidreza Monavari
    Angila Ataei-Pirkooh
    Maryam Esghaei
    Najmeh Moradi
    Roghayeh Babaei
    Atousa Fakhim
    Hossein Keyvani
    Archives of Virology, 2019, 164 : 349 - 357
  • [32] Influence of chronic alcohol abuse on hepatitis C virus replication
    Anand, BS
    Velez, M
    DIGESTIVE DISEASES, 2000, 18 (03) : 168 - 171
  • [33] Chronic alcohol abuse and spontaneous clearance of hepatitis C virus
    Pott Junior, Henrique
    Bricks, Guilherme
    Senise, Jorge Figueiredo
    Castelo, Adauto
    IDCASES, 2019, 17
  • [34] Hepatitis B virus receptors and molecular drug targets
    Verrier, Eloi R.
    Colpitts, Che C.
    Sureau, Camille
    Baumert, Thomas F.
    HEPATOLOGY INTERNATIONAL, 2016, 10 (04) : 567 - 573
  • [35] Hepatitis B virus receptors and molecular drug targets
    Eloi R. Verrier
    Che C. Colpitts
    Camille Sureau
    Thomas F. Baumert
    Hepatology International, 2016, 10 : 567 - 573
  • [36] Review: Molecular epidemiology of hepatitis C virus
    Smith, DB
    Simmonds, P
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (07) : 522 - 527
  • [37] Molecular biological analysis of hepatitis C virus
    Kohara, M
    PROGRESS IN HEPATOLOGY, VOL 2: INTERFERON THERAPY ON CHRONIC HEPATITIS C, 1996, 1113 : 13 - 21
  • [38] Molecular dissection of hepatitis C virus expression
    Okoshi, S
    Takeda, Y
    Takimoto, M
    Shimotohno, K
    Asakura, H
    Jay, G
    INTERVIROLOGY, 2001, 44 (01) : 21 - 28
  • [39] Challenges in molecular epidemiology of hepatitis C virus
    Goncalves Rossi, Livia Maria
    Rahal, Paula
    JOURNAL OF CLINICAL VIROLOGY, 2014, 60 (02) : 81 - 83
  • [40] Phylogeny and molecular evolution of the hepatitis C virus
    Jackowiak, Paulina
    Kuls, Karolina
    Budzko, Lucyna
    Mania, Anna
    Figlerowicz, Magdalena
    Figlerowicz, Marek
    INFECTION GENETICS AND EVOLUTION, 2014, 21 : 67 - 82